Report Overview
The Brazil Vaccines market size was valued at USD 1.5 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of xx% from 2019 to 2028.
The COVID-19 pandemic has boosted that vaccine development by manifolds, and Brazil being one of the adversely affected countries. Brazilian National Immunization Program (PNI) has taken been investing continuously in the development and distribution of vaccine to people. Moreover, even the pharmaceutical companies are focussing on research and development of COVID-19 related diagnostics, treatments, vaccines. All these factors are estimated to impact the Brazilian vaccines market as well in the future.
Market Drivers
Some major market drivers are increasing government funding for vaccine development pertaining to COVID-19 situation, increasing disease prevalence in developing countries, and growing incidence of cancer & HIV.
Major pitfalls in the market are high cost of vaccine storage and transportation, strict regulations for the approval and drug-development hurdles.
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.